Literature DB >> 1328989

Overexpression of the N-ras proto-oncogene, not somatic mutational activation, associated with malignant tumors in transgenic mice.

R Mangues1, I Seidman, J W Gordon, A Pellicer.   

Abstract

We have produced transgenic mice that carry a foreign gene construct consisting of the N-ras proto-oncogene driven by the mouse mammary tumor virus (MMTV) long terminal repeat. Overexpression of the normal N-ras gene is associated with development of hyperplasias and tumors in a variety of tissues. The tumors are clearly malignant, as evidenced by the presence of metastatic lesions. Extensive analysis of the foreign ras gene in these tumors by use of polymerase chain reaction and sequencing demonstrates in all cases the absence of somatically acquired mutations at those codons normally associated with activation of the ras genes. Thus, these tumors develop from overexpression of the proto-oncogene rather than the presence of the mutated oncogene. These data demonstrate that overexpression of a protooncogene of the ras family can predispose cells in vivo to fully malignant behavior.

Entities:  

Mesh:

Year:  1992        PMID: 1328989

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  11 in total

1.  Dominant transformation by mutated human ras genes in vitro requires more than 100 times higher expression than is observed in cancers.

Authors:  V Y Hua; W K Wang; P H Duesberg
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-02       Impact factor: 11.205

Review 2.  RAS inhibitors in hematologic cancers: biologic considerations and clinical applications.

Authors:  D M Beaupre; R Kurzrock
Journal:  Invest New Drugs       Date:  1999       Impact factor: 3.850

3.  The oncoprotein kinase chaperone CDC37 functions as an oncogene in mice and collaborates with both c-myc and cyclin D1 in transformation of multiple tissues.

Authors:  L Stepanova; M Finegold; F DeMayo; E V Schmidt; J W Harper
Journal:  Mol Cell Biol       Date:  2000-06       Impact factor: 4.272

4.  Elevated phosphate activates N-ras and promotes cell transformation and skin tumorigenesis.

Authors:  Corinne E Camalier; Matthew R Young; Gerd Bobe; Christine M Perella; Nancy H Colburn; George R Beck
Journal:  Cancer Prev Res (Phila)       Date:  2010-02-09

Review 5.  The biology of mammary transgenes: five rules.

Authors:  R D Cardiff
Journal:  J Mammary Gland Biol Neoplasia       Date:  1996-01       Impact factor: 2.673

6.  MGSA/GRO-mediated melanocyte transformation involves induction of Ras expression.

Authors:  D Wang; W Yang; J Du; M N Devalaraja; P Liang; K Matsumoto; K Tsubakimoto; T Endo; A Richmond
Journal:  Oncogene       Date:  2000-09-21       Impact factor: 9.867

Review 7.  Mechanisms by which docosahexaenoic acid and related fatty acids reduce colon cancer risk and inflammatory disorders of the intestine.

Authors:  Robert S Chapkin; Jeongmin Seo; David N McMurray; Joanne R Lupton
Journal:  Chem Phys Lipids       Date:  2008-03-04       Impact factor: 3.329

Review 8.  Role of CXCL1 in tumorigenesis of melanoma.

Authors:  Punita Dhawan; Ann Richmond
Journal:  J Leukoc Biol       Date:  2002-07       Impact factor: 4.962

9.  Nras overexpression results in granulocytosis, T-cell expansion and early lethality in mice.

Authors:  Louise Berkhoudt Lassen; Borja Ballarín-González; Alexander Schmitz; Annette Füchtbauer; Finn Skou Pedersen; Ernst-Martin Füchtbauer
Journal:  PLoS One       Date:  2012-08-02       Impact factor: 3.240

10.  Genetic and genomic analysis modeling of germline c-MYC overexpression and cancer susceptibility.

Authors:  Xavier Solé; Pilar Hernández; Miguel López de Heredia; Lluís Armengol; Benjamín Rodríguez-Santiago; Laia Gómez; Christopher A Maxwell; Fernando Aguiló; Enric Condom; Jesús Abril; Luis Pérez-Jurado; Xavier Estivill; Virginia Nunes; Gabriel Capellá; Stephen B Gruber; Víctor Moreno; Miguel Angel Pujana
Journal:  BMC Genomics       Date:  2008-01-11       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.